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Abstract
Introduction: Obesity’s association with hand osteoarthritis cannot be fully explained by mechanical loading. We examined
the relationship between adipokines and radiographic hand osteoarthritis severity and pain.
Methods: In a pilot study of 44 hand osteoarthritis patients (39 women and 5 men), serum adipokine concentrations and
hand x-ray Kallman-scores were analyzed using linear regression models. Secondary analyses examined correlates of hand
pain.
Results: The cohort had a mean age of 63.5 years for women and 72.6 for men; mean (standard deviation) Kallman-scores
were 43.3(17.4) for women and 46.2(10.8) for men. Mean body-mass-index was 30 kg/m
2 for women and men. Mean leptin
concentration was 32.2 ng/ml (women) and 18.5 ng/ml (men); mean adiponectin-total was 7.9 ng/ml (women) and 5.3 ng/
ml (men); mean resistin was 7.3 ng/ml (women) and 9.4 ng/ml (men). No association was found between Kallman-scores
and adipokine concentrations (R
2=0.00–0.04 unadjusted analysis, all p-values.0.22). Secondary analyses showed mean
visual-analog-scale pain of 4.8(2.4) for women and 6.6(0.9) for men. Leptin, BMI, and history of coronary artery disease were
found to be associated with visual-analog-scale scores for chronic hand pain (R
2=0.36 unadjusted analysis, p-values#0.04).
Conclusion: In this pilot study, we found that adipokine serum concentrations were not associated with hand osteoarthritis
radiographic severity; the most important correlates of joint damage were age and disease duration. Leptin serum
concentration, BMI, and coronary artery disease were associated with the intensity of chronic hand OA pain.
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Introduction
Osteoarthritis (OA) is the most common joint disease worldwide
and can affect any joint [1]. OA-related disability and joint
surgeries pose high costs to individuals and society [1]. Obesity is a
known risk factor, presumably due to excessive joint loading [2].
Intriguingly, studies also suggest an association between obesity
and osteoarthritis of the hand, a non-weight bearing joint [2]. The
mechanism underpinning this association, however, is not clear.
Studies have linked the adipocyte-secreted adipokine hormones
(leptin, adiponectin, and resistin) with diseases of cartilage, such as
OA [3]. We chose to examine hand OA and its potential
association with adipokines as a model to minimize the
confounding effect of mechanical loading on joints due to
weight-bearing. We recruited a cohort of 44 hand OA patients
and examined the cross-sectional relationship of adipokine serum
concentrations with hand OA radiographic severity and pain.
Patients and Methods
Study Population
Eligible participants were identified through a centralized
clinical data registry, the Partners Research Patient Data Registry
(RPDR). We selected subjects from this population using the
following inclusion criteria: hand OA [4], age.45 years,
availability of at least one hand x-ray for review, and at least
one outpatient visit at our hospital since January 1, 2008.
Exclusion criteria included inflammatory or active crystalline
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e47860arthritis, intra-articular fracture history, diagnosis of significant
medical comorbidities, or pregnancy.
Recruitment Method
Per study protocol approved by Partners Health Care Institu-
tional Review Board, we sent invitation letters to eligible patients.
The first author (MM) made follow-up phone calls with
preliminary screening. Eligible subjects were invited for the study
visit. After giving written consent, subjects received an interview, a
hand-examination, and phlebotomy. All samples were collected in
mornings after overnight fast. This work was approved by
Brigham and Women’s Partners Institutional Review Board.
Data Elements
The study outcome was the Kallman hand OA x-ray score [5].
The most recent hand x-ray was graded by a rheumatologist (MM)
trained by a board-certified musculoskeletal radiologist (JP), using
Kallman scoring system on a scale of 0–99 [5–7]. If bilateral hand
x-rays were available, the worse side was selected for assessment.
Ten randomly selected hand x-rays were scored by MM, at two
separate occasions a few weeks apart, with prior scores blinded.
The intra-rater reliability estimated by the intra-class correlation
coefficient was 0.78. These 10 hand x-rays were also graded by
musculoskeletal radiologist (JP) with prior scores blinded. Inter-
rater reliability was estimated by intra-class correlation of 0.71. At
the visit, subjects reported the intensity of chronic hand pain on a
visual-analog-scale (VAS), as a response to the question: ‘‘On an
average day, what is the typical score for your hand pain?’’ [8].
Confounders assessed were age, gender, race, body-mass-index,
family history of OA, history of polyarticular OA, history of
coronary artery disease (CAD), history of thyroid disease, diabetes
mellitus (DM), and hand OA disease duration estimated from the
time of initial onset of hand pain.
Biochemical Assays
All specimens were processed in Harvard Catalyst Central
Laboratory, 221 Longwood Avenue, Boston, MA 02115. Serum
leptin Radioimmunological Assay Kit brand was Millipore, St.
Charles, Missouri; adiponectin multimeric enzyme-linked immu-
nosorbent assay (ELISA) Kit brand was ALPCO Diagnostics Inc,
Salem, NH; and resistin Quantikine ELISA Kit brand was R&D
Systems, Minneapolis, MN. The Intra-assay variation and inter-
assay variation were 5.2–7.5% and 3.2–8.9% for leptin; 5.0–5.4%
and ,6% for adiponectin total; 3.3–5.0% and ,6% for
adiponectin high molecular weight fraction; 10.2–13.7% and
,14% for adiponectin middle molecular weight fraction; and 1.8–
7.7% and 3.4–9.3% or resistin.
Statistical Analysis
The primary analyses examined the relationship between
Kallman scores and adipokine concentrations. To perform
secondary analyses on the relationship of hand pain VAS scores
with adipokines, we excluded subjects with co-morbidities
potentially contributing to hand pain, such as fibromyalgia,
hepatitis C, and carpel tunnel syndrome.
Both unadjusted and multivariable adjusted linear regression
models were performed. We also performed adjusted analyses of
all covariates without forcing in adipokine serum concentrations.
The validity of model assumptions was assessed using analysis of
residuals. Statistical significance was assessed by examining p-
values at a two-sided significance level of 0.05 unless otherwise
stated. We used SAS 9.3 (SAS Institute, Inc, Cary, North
Carolina) for all analysis.
Results
We reviewed 2316 medical charts from the RPDR, of which
376 were found to meet the study criteria. Primary rheumatolo-
gists approved 210 patients for investigators to contact. Forty-five
(21% of women and 25% of men contacted) consented to the
study. For patients who did not consent to the study, the average
age was 62 for women and 69 for men, similar to that of the
participants (Table 1). The common reasons for refusal were
inconvenience, transportation difficulties, weather, health prob-
lems unrelated to hand OA, and inability to fast overnight.
Table 1. Demographics, Disease Characteristics, and




Mean ± SD or N (%)
Age 63.568.3 72.668.4
Age
45–50 2 (5.1) 0
51–60 11 (28.2) 0
61–70 14 (35.9) 2 (40.0)
71–80 12 (30.8%) 2 (40.0)




Normal (BMI,25) 9 (23.1) 0
Overweight (25#BMI,30) 11 (28.2) 4 (80.0)
Obese (BMI$30) 19 (48.7) 1 (20.0)
Race/ethnicity
Non-Hispanic White 34 (87.2) 5 (100.0)
Non-Hispanic Black 1 (2.6)
Hispanic 3 (7.7)
Other 1 (2.6)
Osteoarthritis family history 30 (76.9) 4 (80.0)
Polyarticular osteoarthritis 33 (84.6) 3 (60.0)
Current smoking 4.0 (10.3) 0.0 (100.0)
History of Coronary Artery Disease 1 (2.3) 0
History of Thyroid Disease 14 (31.8) 0
Diabetes Mellitus 8 (18.2) 0
NSAIDs 7 (18) 1 (20)
Osteoarthritis disease duration (years) 8.966.7 8.664.4
Leptin (ng/mL) 32.2623.5 18.5613.4
Adiponectin high MW (ug/mL) 4.862.9 2.562.2
Adiponectin mid MW (ug/mL) 1.460.5 1.060.2
Adiponectin total (ug/mL) 7.963.6 5.361.0
Resistin (ng/mL) 7.363.5 9.461.5
Hand x ray Kallman scores 43.3617.4 46.2610.8
Pain (VAS 0–100 mm)* 47.7623.7 66.068.9
Leptin/Adiponectin total ratio (10
23)4 . 9 63.7 3.662.7
Notes: BMI, body mass index. MW, molecular weight.
*Data summarized from participants who entered secondary analysis of
adipokines and pain (35 women and 5 men).
doi:10.1371/journal.pone.0047860.t001
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concentrations are shown in Table 1. All participants met hand
OA classification criteria except one female patient with early OA
symptoms, who did not enter into the analysis. The final study
cohort consisted of 39 women (mean age 63.5) and 5 men (mean
age 72.6). The majority of the participants were white (89%). Eight
patients took non-steroid-anti-inflammatories (NSAIDs) for hand
OA pain as intermittent analgesics, which included celecoxib,
naproxen, ibuprofen, and meloxicam. Mean (standard deviation)
Kallman scores were 43.3(17.4) in females and 46.2(10.8) in males.
Table 2 provides the results of unadjusted and multivariable
adjusted linear regression models analyzing the relationship
between Kallman scores and adipokine serum concentrations.
The unadjusted analyses demonstrated that adipokines were not
related to Kallman scores (R
2 ranged from 0.00–0.05 in
unadjusted analysis, all p-values.0.22). In analyses adjusted for
gender, history of CAD, thyroid disease, and DM, only age
(p,0.01) and OA disease duration (p,0.03) were found to be
significantly associated with Kallman scores.
Table 3 provides the results of the secondary analysis for hand
pain. In multivariable analyses, leptin serum concentration, BMI,
and history of coronary artery disease were associated with hand
pain (R
2=0.36, all p-values,0.05). Of these three, only BMI was
positively associated. Of note, in the adjusted analyses, resistin,
ratio of leptin/adiponectin, history of thyroid disease, and gender
showed R
2=0.31–0.36 and p-values of 0.05–0.20. Radiographic
hand OA severity was also not associated with VAS pain score
(R
2=0.0018 in unadjusted analysis, all p-values=0.87).
Discussion
Given that prior work suggested an association between
adipokines and OA [3,9,10], we assessed the cross-sectional
relationship between adipokines and Kallman hand x-ray scores.
A secondary analysis examined adipokines’ relationship with hand
Table 2. Unadjusted and Adjusted Analyses of Hand X-ray Kallman Score as a Function of Each Adipokine and Significant
Determinants.
Unadjusted Analysis
Multivariable Linear Regression Adjusted
Analysis*
b SE P R
2 b SE P R
2
Women Only
Leptin 0.15 0.12 0.21 0.05 0.07 0.11 0.50 0.39
Adiponectin HMW 1.01 0.96 0.30 0.03 0.14 0.86 0.87 0.38
Adiponectin MMW 3.20 5.21 0.54 0.01 25.05 4.93 0.31 0.40
Adiponectin Total 0.83 0.78 0.30 0.03 20.05 0.71 0.95 0.38
Resistin 20.20 0.83 0.81 0.00 20.06 0.73 0.93 0.38
Ratio Lep/Adip Total 0.33 0.76 0.66 0.01 0.75 0.65 0.26 0.40
Age 1.09 0.30 0.00 0.27 0.85 0.33 0.01
" 0.38
Disease Duration 1.16 0.38 0.00 0.20 0.73 0.40 0.08
" 0.38
Coronary.Art. Disease. 8.92 17.79 0.62 0.01 1.82 16.32 0.91 0.38
Thyroid Disease 5.65 0.34 0.34 0.02 4.35 5.08 0.40 0.38
Diabetes Mellitus 26.36 6.91 0.36 0.02 25.43 5.90 0.36 0.38
Women and Men
Leptin 0.14 0.11 0.22 0.04 0.07 0.10 0.51 0.35
Adiponectin HMW 0.92 0.89 0.31 0.02 0.15 0.81 0.85 0.35
Adiponectin MMW 2.63 4.83 0.59 0.01 23.84 4.45 0.39 0.36
Adiponectin Total 0.77 0.73 0.30 0.03 20.03 0.67 0.97 0.34
Resistin 20.15 0.77 0.85 0.00 20.12 0.66 0.86 0.35
Ratio Lep/Adip Total 0.29 0.71 0.69 0.00 0.64 0.60 0.29 0.36
Age 0.95 0.26 0.00 0.24 0.84 0.27 0.00
" 0.34
Disease Duration 1.11 0.36 0.00 0.19 0.80 0.35 0.03
" 0.34
Gender 22.89 8.01 0.72 0.00 4.53 7.12 0.53 0.34
Coronary Art. Disease 8.56 17.04 0.62 0.01 2.26 15.60 0.89 0.37
Thyroid Disease 4.83 5.42 0.38 0.02 4.30 4.90 0.39 0.37
Diabetes Mellitus 26.58 6.53 0.32 0.02 25.37 5.70 0.35 0.37
Notes: In adjusted analyses, we retained only gender, history of coronary artery disease, thyroid disease, and diabetes mellitus, and the statistically significant covariates
(age, disease duration), selected during model building as defined by p,0.10. Unadjusted linear regression analysis was not performed in male participants due to the
small sample size (N=5). HMW, High Molecular Weight. MMW, Middle Molecular Weight. b refers to the beta coefficient estimated in linear regression models. SE,
standard error.
"With adipokine serum concentrations not forced into the models, and adjusted for gender, history of coronary artery disease, thyroid disease, and diabetes mellitus,
only age and osteoarthritis disease duration were associated with Kallman scores, while history of coronary artery disease, thyroid disease, diabetes mellitus, and gender
were insiginificant, as defined by p-value.0.05.
doi:10.1371/journal.pone.0047860.t002
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study found leptin, BMI, and history of coronary artery disease
were associated with chronic pain intensity of hand OA.
In a longitudinal study on radiographic hand OA progression
and adipokines by Yusuf et al., radiographic joint space narrowing
scores were analyzed, focusing on the cartilage component of joint
changes [9]. Adiponectin was found to be associated with lower
risk for hand OA radiographic progression [9]. In a cross-sectional
study on adipokines and hand OA by Choe et al., using modified
Kellgren-Lawrence scoring, radiographic changes in joints were
classified into groups with or without radiographic hand OA [10].
Their analyses suggested cross-sectional association of serum
resistin levels and radiographic hand OA [10]. However, our
studies did not find evidence to support the association between
adipokine serum concentrations and radiographic severity of hand
OA. Literature also suggested an association between coronary
artery disease and hand OA radiographic severity, but our study
did not provide supporting evidence for this hypothesis [13,14].
It is important to consider the strengths and limitations of our
study. Our study used a newly recruited cohort. In addition, we
used validated Kallman grading that offers a continuous numeric
scoring and comprehensive surveillance of joint components
including both cartilage and bone in most joints implicated in
hand OA [5–7]. This further allowed linear regression modeling
and afforded greater sensitivity to capture a relationship.
Several considerations limit the interpretation of our result. Our
sample size was small, precluding our capacity to detect small but
potentially clinically important effects. Blood samples were not
collected simultaneously with the x-rays, in some cases 2–3 years
apart. However, studies have suggested that the intra-individual
adipokine system remains stable over time [15,16]. Prior studies
presented evidence to validate the utility of single adipokine
measurements in population-based analyses [15,16]. VAS pain
scores were based on the assessments of the ‘‘typical pain score on
an average day’’ and therefore represented chronic pain level in
Table 3. Unadjusted and Adjusted Linear Regression Analyses of Pain as a Linear Function of Each Adipokine and Significant
Determinants.
Unadjusted Analyses
Multivariable Linear Regression Adjusted
Analyses
b SE P R
2 b SE P R
2
Women Only
Leptin 0.01 0.02 0.40 0.02 20.05 0.03 0.06 0.30
Adiponectin HMW 20.01 0.16 0.94 0.00 0.07 0.15 0.62 0.22
Adiponectin MMW 20.07 0.83 0.93 0.00 0.22 0.85 0.79 0.22
Adiponectin Total 20.02 0.13 0.90 0.00 0.04 0.12 0.74 0.22
Resistin 20.12 0.11 0.29 0.03 20.19 0.11 0.08 0.30
Ratio Lep/Adip Total 0.10 0.11 0.35 0.03 20.20 0.16 0.23 0.25
Coronary Art. Disease 23.89 2.34 0.11 0.08 24.42 2.33 0.06 0.21
Thyroid Disease 0.50 0.82 0.55 0.01 0.78 0.79 0.33 0.21
Diabetes Mellitus 0.62 0.96 0.52 0.01 0.43 0.90 0.64 0.21
Body mass index 0.10 0.05 0.07 0.10 0.10 0.05 0.06 0.21
X-ray Scores 20.01 0.02 0.81 0.00 N/A N/A N/A N/A
Women and Men
Leptin 0.01 0.02 0.59 0.01 20.05 0.03 0.04
" 0.36
Adiponectin HMW 20.09 0.14 0.55 0.01 0.07 0.14 0.62 0.28
Adiponectin MMW 20.35 0.78 0.66 0.01 0.20 0.79 0.80 0.28
Adiponectin Total 20.07 0.12 0.57 0.01 0.04 0.12 0.74 0.28
Resistin 20.09 0.11 0.42 0.02 20.20 0.10 0.05 0.35
Ratio Lep/Adip Total 0.08 0.10 0.44 0.02 20.19 0.15 0.20 0.31
Body mass index 0.10 0.05 0.06 0.09 0.24 0.08 0.00
" 0.36
Coronary Art. Disease 24.10 2.27 0.08 0.08 25.68 2.18 0.01
" 0.36
Thyroid Disease 0.11 0.78 0.89 0.00 0.94 0.71 0.20 0.36
Diabetes Mellitus 0.31 0.92 0.74 0.00 0.71 0.82 0.40 0.36
Gender 21.82 1.08 0.10 0.07 21.60 1.06 0.14 0.36
X-ray scores 20.00 0.02 0.87 0.00 N/A N/A N/A N/A
Notes: In adjusted analyses, we retained only gender, history of coronary artery disease, thyroid disease, and diabetes mellitus, and the other significant covariates
selected during model building as defined by p value,0.10. Unadjusted linear regression analysis was not performed in male participants due to the small sample size
(N=5). HMW, High Molecular Weight. MMW, Middle Molecular Weight. BMI, body mass index. VAS, visual-analog-scale. b refers to the beta coefficient estimated in linear
regression models. SE, standard error.
"With adipokine serum concentrations not forced into the models, adjusted for gender, history of coronary artery disease, thyroid disease, and diabetes mellitus, we
found leptin, BMI, history of coronary artery disease were associated with pain, while thyroid disease, diabetes mellitus, and gender were insiginificant, as defined by p-
value.0.05.
doi:10.1371/journal.pone.0047860.t003
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correlations were moderate (0.71 and 0.78).
It is possible that adipokines and hand OA severity appear not
associated because we missed a temporal window of association.
From a biological standpoint, early hand OA can have distinct
molecular-cellular signatures but can often lack sufficient evidence
for clinical classification. The timing of adipokine involvement in
OA development is also unclear. Should such association exist in
early OA, ACR criteria would not allow the classification of such
cases as OA. Our cross-sectional design would have limited ability
to capture the temporal pattern of such an association.
Further, other factors may confound the relationship between
hand OA radiographic severity and adipokines. Our multivariable
regression model was developed using known and measurable
potential confounders: age, gender, race, BMI, family history,
polyarticular OA, and disease duration. Potential confounders
such as genetic difference, hand anatomical variation, other co-
morbidities, environmental factors, and occupational risk factors
were not included in our analysis.
Lastly, we examined the relationship between adipokines and
hand pain. Gandhi et al. showed that adiponectin-leptin ratio of
knee synovial fluid was associated with the Short Form McGill
Pain Questionnaire score [12]. Our results suggested that leptin
serum concentration, BMI, and history of coronary arterty disease
were associated with chronic pain perception of hand OA. History
of coronary artery disease appeared to have a negative correlation
with the intensity of hand OA pain. This has not been previously
reported based on our literature search, although one should
exercise caution in interpreting this result given the limitations of
this study.
Resistin, ratio of leptin/adiponectin, thyroid disease, and
gender had p values#0.20, suggesting a potential association with
OA pain. The small sample size may not have allowed the
detection of these associations.
Similar to the apparent discordance between knee osteoarthritis
radiographic severity and pain [17], our study suggests that
osteoarthritis radiographic severity and pain may also be
discordant in non-weight bearing joints. Although VAS pain
scores measure only limited components of pain perception, its
effectiveness has been validated and proved comparable to
Western Ontario and McMaster Universities Arthritis Index
(WOMAC) pain subscale [8].
Conclusions
In conclusion, this study did not find supporting evidence for a
cross-sectional association between adipokine serum concentra-
tions and radiographic hand OA severity. The most important
variables for joint damage were age and disease duration. In non-
weight bearing joints, severity of joint damage was not associated
with intensity of osteoarthritic pain. However, BMI, leptin serum
concentration, and history of coronary artery disease were
associated with chronic hand OA pain.
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